Patent · US Expired

Method for the reduction or prevention of post-surgical adhesion formation

US7198786B2 · kind B2 · utility

10Cited by

0References

6Claims

0Family size

Assignees

Baxter International Inc. · US
Baxter Healthcare SA · CH

Inventors

Heinz Redl · Wien, AT
Reiner Spaethe · Starnberg, DE
Manuela Simunek · Wien, AT

Key dates

Filing date	Oct 12, 2001
Grant date	Apr 3, 2007
Priority date	—
Expiry date	Oct 20, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/4833
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Reducing or preventing adhesions which would form in a patient during or after surgery by administering to the wound surface of a patient a fibrinogen solution in an amount of about 0.025 ml fibrinogen/cm2 to about 0.25 ml fibrinogen/cm2 of the surface being at risk for developing adhesions. User of fibrinogen in a preparation comprising fibrinogen at a concentration of 20 to 80 mg/ml for the reduction or prevention of post-surgical adhesion formation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.